Repligen Corporation Fundamental Analysis (NASDAQ: RGEN)
Repligen Corporation Fundamental Analysis (NASDAQ: RGEN)
Repligen Corporation (NASDAQ: RGEN) shows weak financial fundamentals with a PE ratio of 146.74, profit margin of 6.73%, and ROE of 2.46%. The company generates $0.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 46.3/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze RGEN's fundamental strength across five key dimensions:
Efficiency Score
WeakRGEN struggles to generate sufficient returns from assets.
Valuation Score
ModerateRGEN shows balanced valuation metrics.
Growth Score
ModerateRGEN shows steady but slowing expansion.
Financial Health Score
ExcellentRGEN maintains a strong and stable balance sheet.
Profitability Score
ModerateRGEN maintains healthy but balanced margins.
Key Financial Metrics
Is RGEN Expensive or Cheap?
P/E Ratio
RGEN trades at 146.74 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, RGEN's PEG of 0.05 indicates potential undervaluation.
Price to Book
The market values Repligen Corporation at 3.57 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 43.04 times EBITDA. This signals the market has high growth expectations.
How Well Does RGEN Make Money?
Net Profit Margin
For every $100 in sales, Repligen Corporation keeps $6.73 as profit after all expenses.
Operating Margin
Core operations generate 8.81 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.46 in profit for every $100 of shareholder equity.
ROA
Repligen Corporation generates $1.75 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Repligen Corporation produces operating cash flow of $130.83M, showing steady but balanced cash generation.
Free Cash Flow
Repligen Corporation generates strong free cash flow of $104.21M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.85 in free cash annually.
FCF Yield
RGEN converts 1.39% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
146.74
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.57
vs 25 benchmark
P/S Ratio
Price to sales ratio
9.87
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.33
vs 25 benchmark
Current Ratio
Current assets to current liabilities
9.20
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.02
vs 25 benchmark
How RGEN Stacks Against Its Sector Peers
| Metric | RGEN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 146.74 | 29.34 | Worse (Expensive) |
| ROE | 2.46% | 470.00% | Weak |
| Net Margin | 6.73% | -71064.00% (disorted) | Weak |
| Debt/Equity | 0.33 | 0.84 | Strong (Low Leverage) |
| Current Ratio | 9.20 | 5.17 | Strong Liquidity |
| ROA | 1.75% | -26.00% (disorted) | Weak |
RGEN outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Repligen Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation